pI: 5.6015 |
Length (AA): 438 |
MW (Da): 49289 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 436 | 1e32 (A) | 29 | 452 | 29.00 | 0 | 1 | 1.25 | 0.1 |
181 | 424 | 1lv7 (A) | 153 | 395 | 40.00 | 0 | 1 | 1.13 | -1.06 |
24 | 438 | 5c18 (A) | 319 | 757 | 28.00 | 0.026 | 1 | 1.22219 | 0.51 |
172 | 431 | 3h4m (A) | 159 | 418 | 57.00 | 0.0013 | 1 | 1.36031 | -1.21 |
354 | 428 | 4a3v (B) | 380 | 454 | 31.00 | 0 | 0.62 | 0.645133 | -1.33 |
359 | 420 | 2dzn (D) | 349 | 410 | 40.00 | 0 | 1 | 0.690453 | -0.8 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127456)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G29040 | regulatory particle AAA-ATPase 2A |
Arabidopsis thaliana | AT2G20140 | 26S proteasome subunit RPT2B |
Babesia bovis | BBOV_IV009290 | 26S protease regulatory subunit 4, putative |
Brugia malayi | Bm1_52520 | Probable 26S protease regulatory subunit 4 |
Candida albicans | CaO19.5440 | likely ATPase similar to S. cerevisiae RPT2 (YDL007W) ATPase subunit of the 19S regulatory particle of the 26S proteasome |
Candida albicans | CaO19.12895 | likely ATPase similar to S. cerevisiae RPT2 (YDL007W) ATPase subunit of the 19S regulatory particle of the 26S proteasome |
Caenorhabditis elegans | CELE_F29G9.5 | Protein RPT-2 |
Cryptosporidium hominis | Chro.40138 | 26S proteasome AAA-ATPase subunit RPT2a |
Cryptosporidium parvum | cgd4_1170 | 26S proteasome regulatory subunit S4 like AAA ATpase |
Dictyostelium discoideum | DDB_G0270784 | 26S protease regulatory subunit 4 |
Drosophila melanogaster | Dmel_CG5289 | Regulatory particle triple-A ATPase 2 |
Echinococcus granulosus | EgrG_001101900 | proteasome 26s subunit subunit 4 atpase |
Entamoeba histolytica | EHI_180350 | 26S protease regulatory subunit, putative |
Echinococcus multilocularis | EmuJ_001101900 | proteasome 26s subunit subunit 4 atpase |
Giardia lamblia | GL50803_113554 | 26S proteasome ATPase subunit S4, putative |
Homo sapiens | ENSG00000100764 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
Leishmania braziliensis | LbrM.13.0890 | proteasome regulatory ATPase subunit 2, putative |
Leishmania donovani | LdBPK_130990.1 | proteasome regulatory ATPase subunit 2, putative |
Leishmania infantum | LinJ.13.0990 | proteasome regulatory ATPase subunit 2, putative |
Leishmania major | LmjF.13.1090 | proteasome regulatory ATPase subunit 2, putative |
Leishmania mexicana | LmxM.13.1090 | proteasome regulatory ATPase subunit 2, putative |
Loa Loa (eye worm) | LOAG_00367 | RPT-2 protein |
Mus musculus | ENSMUSG00000021178 | protease (prosome, macropain) 26S subunit, ATPase 1 |
Oryza sativa | 4344373 | Os07g0691800 |
Oryza sativa | 4332553 | Os03g0298400 |
Plasmodium berghei | PBANKA_1206600 | 26S protease regulatory subunit 4, putative |
Plasmodium falciparum | PF3D7_1008400 | 26S protease regulatory subunit 4, putative |
Plasmodium knowlesi | PKNH_0807400 | 26S protease regulatory subunit 4, putative |
Plasmodium vivax | PVX_094615 | 26S protease regulatory subunit 4, putative |
Plasmodium yoelii | PY00768 | 26S proteasome subunit 4-like protein |
Saccharomyces cerevisiae | YDL007W | proteasome regulatory particle base subunit RPT2 |
Schistosoma japonicum | Sjp_0210920 | ko:K01509 adenosinetriphosphatase [EC3.6.1.3], putative |
Schistosoma mansoni | Smp_173840 | 26S protease regulatory subunit |
Schmidtea mediterranea | mk4.028015.01 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.028015.02 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.002047.06 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.006173.02 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.013821.02 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.001166.04 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.000265.11 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.000265.02 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.004026.01 | |
Schmidtea mediterranea | mk4.001166.00 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.002047.04 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.012837.00 | 26S protease regulatory subunit 4 |
Schmidtea mediterranea | mk4.001166.01 | |
Schmidtea mediterranea | mk4.010528.01 | 26S protease regulatory subunit 4 |
Trypanosoma brucei gambiense | Tbg972.11.4280 | proteasome regulatory ATPase subunit 2, putative |
Trypanosoma brucei | Tb927.11.3740 | proteasome regulatory ATPase subunit 2 |
Trypanosoma congolense | TcIL3000.11.3690 | proteasome regulatory ATPase subunit 2 |
Trypanosoma cruzi | TcCLB.511859.180 | proteasome regulatory ATPase subunit 2, putative |
Trypanosoma cruzi | TcCLB.511047.50 | proteasome regulatory ATPase subunit 2, putative |
Toxoplasma gondii | TGME49_267080 | 26S protease regulatory subunit 4, putative |
Theileria parva | TP01_0845 | 26S proteasome regulatory subunit 4, putative |
Trichomonas vaginalis | TVAG_074870 | 26S protease regulatory subunit 6A, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.1220 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.1220 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.1220 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.1220 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F29G9.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F29G9.5 | Caenorhabditis elegans | slow growth | wormbase |
YDL007W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1206600 | Plasmodium berghei | Essential | plasmo |
TGME49_267080 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | proteasome (prosome, macropain) 26S subunit, ATPase, 1 | Compounds | References |